Recent Analyst Forecasts and Stock Ratings
Alnylam Pharmaceuticals, Inc. FAQ's
Alnylam Pharmaceuticals, Inc. has been rated by research analysts at Bernstein, Canaccord Genuity, Bank of America Securities, BMO Capital, RBC Capital, Goldman Sachs in the past 90 days.